Targeting binding function-3 site on the androgen receptor to treat Enzalutamide-resistant prostate cancer

被引：0
|
作者：
Munuganti, Ravi Shashi Nayana [1 ]
Hassona, Mohamed D. H. [1 ]
Leblanc, Eric [1 ]
Guns, Emma T. [1 ]
Rennie, Paul S. [1 ]
Cherkasov, Artem [1 ]
机构：
[1] Vancouver Prostate Ctr, Vancouver, BC, Canada
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3654
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Targeting the DNA-binding domain of the androgen receptor in castration-resistant prostate cancer
    Steele, Thomas M.
    Messner, Elisabeth A.
    Tsamouri, Maria Malvina
    Siddiqui, Salma
    Bennion, Brian
    Liu, Ruiwu
    Ghosh, Paramita
    CANCER RESEARCH, 2022, 82 (12)
  • [42] Multivalent peptoid conjugates suppress enzalutamide-resistant prostate cancer cellular proliferation
    Wang, Yu
    Levine, Paul
    Dehigaspitiya, Dilani
    Profit, Adam
    Logan, Susan
    Imberg-Kazdan, Keren
    Kirshenbaum, Kent
    Garabedian, Michael
    CANCER RESEARCH, 2016, 76
  • [43] Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer
    Sternberg, Cora N.
    FUTURE ONCOLOGY, 2019, 15 (13) : 1437 - 1457
  • [44] Aspalathus linearis suppresses cell survival and proliferation of enzalutamide-resistant prostate cancer cells via inhibition of c-Myc and stability of androgen receptor
    Wang, Bi-Juan
    Huang, Shih-Han
    Kao, Cheng-Li
    Muller, Christo J. F.
    Wang, Ya-Pei
    Chang, Kai-Hsiung
    Wen, Hui-Chin
    Yeh, Chien-Chih
    Shih, Li-Jane
    Kao, Yung-Hsi
    Huang, Shu-Pin
    Li, Chia-Yang
    Chuu, Chih-Pin
    PLOS ONE, 2022, 17 (07):
  • [45] Targeting adrenal androgen to treat prostate cancer
    Wu, Yue
    Wang, Jianmin
    Tang, Li
    Pop, Elena
    Stocking, John J.
    Attwood, Kristopher M.
    Smith, Gary J.
    CANCER RESEARCH, 2018, 78 (13)
  • [46] NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells
    Farah, Elia
    Li, Chaohao
    Cheng, Lijun
    Kong, Yifan
    Lanman, Nadia A.
    Pascuzzi, Pete
    Lorenz, Gabrielle Renee
    Zhang, Yanquan
    Ahmad, Nihal
    Li, Lang
    Ratliff, Tim
    Liu, Xiaoqi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (21) : 8543 - 8554
  • [47] Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
    Daksh Thaper
    Sepideh Vahid
    Ramandeep Kaur
    Sahil Kumar
    Shaghayegh Nouruzi
    Jennifer L. Bishop
    Martin Johansson
    Amina Zoubeidi
    Scientific Reports, 8
  • [48] Combination AZD5363 with Enzalutamide Significantly Delays Enzalutamide-resistant Prostate Cancer in Preclinical Models
    Toren, Paul
    Kim, Soojin
    Cordonnier, Thomas
    Crafter, Claire
    Davies, Barry R.
    Fazli, Ladan
    Gleave, Martin E.
    Zoubeidi, Amina
    EUROPEAN UROLOGY, 2015, 67 (06) : 986 - 990
  • [49] New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity
    Hwang, Dong-Jin
    He, Yali
    Ponnusamy, Suriyan
    Mohler, Michael L.
    Thiyagarajan, Thirumagal
    McEwan, Lain J.
    Narayanan, Ramesh
    Miller, Duane D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (02) : 491 - 511
  • [50] Small interfering RNA targeting N-cadherin regulates cell proliferation and migration in enzalutamide-resistant prostate cancer
    Lu, Cheng-Hsin
    Wu, Chun-Hsien
    Hsieh, Pei-Fang
    Wu, Chen-Yu
    Kuo, Wade Wei-Ting
    Ou, Chien-Hui
    Lin, Victor Chia Hsiang
    ONCOLOGY LETTERS, 2022, 23 (03)
12345